Taiwan study tracks best biologic for psoriasis
NCT ID NCT04818385
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study followed 240 adults in Taiwan with moderate-to-severe plaque psoriasis to see how well risankizumab works compared to other biologics in real-world settings. Participants received their prescribed treatment and were monitored for about 2 years. The main goal was to measure how many achieved at least 90% clearer skin (PASI 90).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
risankizumab and other biologics
What this could lead to
If successful, this study could provide real-world evidence on which biologic works best for psoriasis patients in Taiwan, helping doctors choose more effective treatments.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient differences. It does not test a new drug or prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China Medical University Hospital /ID# 229961
Taichung, 40447, Taiwan
-
Hualien Tzu Chi Hospital /ID# 238431
Hualien City, 97002, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 230016
Kaohsiung City, 807, Taiwan
-
Linkou Chang Gung Memorial Hospital /ID# 253775
Taoyuan City, 333, Taiwan
-
National Cheng Kung University Hospital /ID# 253776
Tainan, 704, Taiwan
-
National Taiwan University Hospital - Hsinchu branch /ID# 238432
Hsinchu, 30059, Taiwan
-
National Taiwan University Hospital /ID# 230017
Taipei City, Taipei, 100, Taiwan
-
Taipei Medical University Hospital /ID# 230018
Taipei, 11031, Taiwan